002737.SZ · 葵花药业
China A-shares · RS rating 42 · As of 2026-10-14
| Price | 11.40 CNY |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 63 / 36 / 30 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 12 / 21 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -22.5% |
| Distance from 52-week high | +27.0% |
| Market cap (USD) | $1.0B |